Júlio Gil

Júlio Gil

Auto-generated profile, based on publicly available information

Júlio Gil

Cardiology Department, Tondela-Viseu Hospital Centre, Viseu, Portugal

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
CSCaroline Almeida Soares
Caroline Almeida Soares
JFJoão Gouveia Fiuza
João Gouveia Fiuza
CRCláudio Rodrigues
Cláudio Rodrigues
NCNuno Craveiro
Nuno Craveiro
JPJúlio Gil Pereira
Júlio Gil Pereira
MSMaria Paula Ministro dos Santos
Maria Paula Ministro dos Santos
Background: Morphological and functional cardiac involvement is rarely described in patients with inflammatory bowel disease (IBD) but there is evidence that they have an increased risk of cardiovascular (CV) events despite the lower prevalence of traditional CV risk factors. Objectives: Our systematic review and meta-analysis examined the relationship between IBD and cardiac function, namely the incidence of heart failure (HF) and subclinical echocardiographic changes. Data sources and methods: Two medical databases, PubMed and Scopus, were systematically searched up to September 2022 to identify all studies reporting HF and/or echocardiographic changes in IBD patients. Results: The qualitative analysis comprised a total of 18 studies (14 retrospective and 4 prospective studies) involving 59,838 patients. IBD was associated with subtle systolic and diastolic alterations, vascular dysfunction, increased risk for HF hospitalizations, and globally worse CV outcomes. Nine studies were included in the meta-analysis. In the IBD population, we found statistically significant reduced early to late diastolic transmitral flow (E/A), higher E to early diastolic mitral annular tissue velocity (E/e′), and decreased global longitudinal strain. Increased left atrial diameter and area were also present in IBD patients but no statistical significance was reached. Inter-atrial and right intra-atrial conduction delays were observed. Conclusion: The IBD population has an increased risk for left ventricular and atrial dysfunction, vascular changes, arrhythmias, and HF hospitalization. Screening with sensitive imaging like speckle tracking echocardiography could identify early subclinical changes. IBD is in fact a CV risk factor and tight inflammation control may reduce CV risk.

1 March 2018 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
JGJulio Gil
Julio Gil
BMBruno Marmelo
Bruno Marmelo
LALuís Abreu
Luís Abreu
HAHugo Antunes
Hugo Antunes
LSLuís Ferreira Dos Santos
Luís Ferreira Dos Santos
JCJosé Costa Cabral
José Costa Cabral

14 August 2018 in Netherlands Heart Journal
Verified
Journal Article
Open access
PDF file
JGJ. Gil
J. Gil
LAL. Abreu
L. Abreu
HAH. Antunes
H. Antunes
MGM. L. Gonçalves
M. L. Gonçalves
MPM. I. Pires
M. I. Pires
JCJ. C. Cabral
J. C. Cabral
A 47-year-old man was admitted for acute heart failure. The ECG had low voltage criteria. Transthoracic echocardiogram showed bi-atrial dilation, left ventricular concentric hypertrophy with reduced ejection fraction (LVEF of 48%) and hypertrophy of the right ventricular free wall. There was no valve dysfunction. Two-dimensional speckle-tracking echocardiography showed an apical sparing pattern of longitudinal strain (Fig. 1). Electrophoresis of serum proteins and bone marrow biopsy confirmed multiple myeloma. This suggested AL-type amyloidosis, and abdominal fat biopsy demonstrated amyloid-like, birefringent substance deposition in polarised light. Chemotherapy was started, remission occurred, and the patient remained stable after over 3 years of follow-up. Amyloidosis is a multi-systemic disease characterised by the deposition of amyloid fibrils, cardiac involvement being usually associated with poor prognosis [1, 2]. Relative sparing of longitudinal strain in the left ventricular apex, which may be related to less amyloid deposition occurring in the apex than in the base, is highly sensitive and specific for the diagnosis of cardiac amyloidosis [1, 2].

1 April 2017 in Journal of Cardiology Cases
Verified
Journal Article
Closed access
JGJúlio Gil
Júlio Gil
BMBruno Marmelo
Bruno Marmelo
LALuís Abreu
Luís Abreu
HAHugo Antunes
Hugo Antunes
LSLuís Ferreira dos Santos
Luís Ferreira dos Santos
JCJosé Costa Cabral
José Costa Cabral

1 January 2019 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
JGJúlio Gil
Júlio Gil
LALuís Abreu
Luís Abreu
HAHugo Antunes
Hugo Antunes
MGMaria Luísa Gonçalves
Maria Luísa Gonçalves
MPMaria Inês Pires
Maria Inês Pires
JSJorge Oliveira Santos
Jorge Oliveira Santos
Background: Multiple risk scores (RS) are approved in the prediction of worse prognosis in acute coronary syndromes (ACS). Recently, the Portuguese Journal of Cardiology has proposed the ProACS RS. Objective: Application of several validated RS, as well as ProACS in patients, admitted for ACS. Evaluation of each RS's performance in predicting in-hospital mortality and the occurrence of all-cause mortality or non-fatal ACS at one-year follow-up and compare them to the ProACS RS. Methods: A retrospective study of ACS was performed. The following RS were applied: GRACE, ACTION Registry-GWTG, PURSUIT, TIMI, EMMACE, SRI, CHA2DS2-VASc-HS, C-ACS and ProACS. ROC Curves were created to determine the predictive power for each RS and then were directly compared to ProACS. Results: The ProACS, ACTION Registry-GWTG and GRACE showed a c-statistics of 0.908, 0.904 and 0.890 for predicting in-hospital mortality, respectively, performing better in ST-segment elevation myocardial infarction patients. The other RS performed satisfactorily, with c-statistics over 0.750, apart from the CHA2DS2-VASc-HS and C-ACS which underperformed. All RS underperformed in predicting worse long-term prognosis revealing c-statistics under 0.700. Conclusion: ProACS is an easily obtained risk score for early stratification of in-hospital mortality. When evaluating all RS, the ProACS, ACTION Registry-GWTG and GRACE RS showed the best performance, demonstrating high capability of predicting a worse prognosis. ProACS was able to demonstrate statistically significant superiority when compared to almost all RS. Thus, the ProACS has showed that it is able to combine simplicity in the calculation of the score with good performance in predicting a worse prognosis.

1 January 2017 in Journal of Clinical Medicine Research
Verified
Journal Article
Open access
JGJulio Gil
Julio Gil
HAHugo Antunes
Hugo Antunes
BMBruno Marmelo
Bruno Marmelo
LALuis Abreu
Luis Abreu
MGMaria Luisa Goncalves
Maria Luisa Goncalves
JCJose Costa Cabral
Jose Costa Cabral
Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (P-MAIVF) is a rare complication of infective endocarditis and trauma, particularly of aortic valve surgery. Clinical symptoms are usually unspecific and generally due to complications. Transesophageal echocardiography (TEE) is the most commonly used exam to diagnose P-MAIVF. The main echocardiographic feature is the presence of a cavity communicating with the left ventricular outflow tract that expands during systole and collapses during diastole. Most frequent complications are formation of a fistulous tract and compression of adjacent structures. Surgical correction is usually the treatment of choice. The authors describe a case of a female patient with a septic shock of unclear origin. After antibiotic therapy and organ-supporting measures without apparent improvements, a TEE revealed infective endocarditis, complicated with P-MAIVF. Despite adequate treatment, the patient did not survive for long enough to be submitted to surgical repair.